| 1 |
33588721 | Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic Treatment. | 2021 Oct 5 |
1 |
| 2 |
32572118 | Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia. | 2020 Jun 22 |
1 |
| 3 |
29160620 | DNA methylation of membrane-bound catechol-O-methyltransferase in Malaysian schizophrenia patients. | 2018 Apr |
1 |
| 4 |
29255361 | Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia. | 2017 |
5 |
| 5 |
26491028 | Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naïve First Episode Psychosis. | 2016 Oct |
2 |
| 6 |
25042870 | Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers. | 2014 Sep |
1 |
| 7 |
22560999 | Impact of catechol-o-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its potential clinical significance. | 2012 Jul |
3 |
| 8 |
22935916 | Association between a COMT polymorphism and clinical response to risperidone treatment: a pharmacogenetic study. | 2012 Dec |
5 |
| 9 |
20053459 | Interaction of catechol-O-methyltransferase (COMT) Val108/158 Met genotype and risperidone treatment in Chinese Han patients with schizophrenia. | 2010 Mar 30 |
2 |
| 10 |
19290789 | Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment. | 2009 Mar |
1 |
| 11 |
19451915 | Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia. | 2009 Oct |
1 |
| 12 |
14610521 | Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone. | 2003 |
1 |